Dan Oran

Former Executive (Strategy/Corporate Development)

Therapeutic Areas

Drug	Indication	Phase
NEX-1 / NEX-2	Rett Syndrome	Pre-clinical / Phase 1
Cannabidiol Program	Dravet Syndrome	Pre-clinical